[A new drug, the hydrochloride of the beta-dimethylaminoethylic ester of alpha, alpha-diphenyl-alpha-propargoxyacetic acid in therapy of gastroduodenal disorders].
D000138:Acidosis / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000480:Alkynes / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use*; D004158:Diphenylacetic Acids / Q000627:therapeutic use*; D004415:Dyspepsia / Q000188:drug therapy; D004751:Enteritis / Q000188:drug therapy; D004983:Ethanolamines / Q000627:therapeutic use; D005260:Female; D005756:Gastritis / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006356:Heartburn / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000188:drug therapy; D010437:Peptic Ulcer / Q000188:drug therapy; D014839:Vomiting / Q000188:drug therapy
D000480:Alkynes; D000863:Antacids; D004158:Diphenylacetic Acids; D004983:Ethanolamines; D005765:Gastrointestinal Agents
Un nuovo farmaco, il cloridrato dell'estere beta-dimetilaminoetilico dell'acido alfa, alfa-difenil-alfa-propargossiacetico nella terapia delle affezioni gastroduodenali.